• Mon. Jul 15th, 2024

Serum Institute Developed Vaccine To Protect From JN.1: Dr. Balram

Serum Institute Developed Vaccine To Protect From JN.1: Dr. BalramSerum Institute Developed Vaccine To Protect From JN.1: Dr. Balram

Hyderabad, Dec 28 (Hydnow): Allaying fears among people following the surge of covid infections due to JN.1 the new sub-variant of the coronavirus, former Director General of Indian Council of Medical Research (ICMR), Dr. Balram Bhargava said that initial signs of the recent rise of covid cases clearly indicate mild infections.  

Dr. Bhargava, who played a central role in the country’s response during the three waves of the Covid pandemic, said the Serum Institute was developing a vaccine that has the potential to provide protection even from the recently identified JN.1 sub-variant. 

“Serum Institute has a vaccine based on nanotechnology, which has been exported to the United States.  While it is still early days, this vaccine has a lot of promise and appears to be effective against the JN.1, he said. (Hydnow) 

Advertisements


Next Story :

Now you can get the latest stories from Hydnow every day. Click the link to subscribe. Click to follow Hydnow’s Facebook page and Twitter and Instagram

Leave a Reply

Your email address will not be published. Required fields are marked *